Furthermore, Egusquiaguirre et al. have demonstrated that elevated TNFRSF1A levels may predict a subset of breast tumours that are sensitive to STAT3 transcriptional inhibitors [34]. This evidence concerns the gene TNFRSF1A and breast neoplasm.